(Q37419047)

20 August 2017

1 reference

title

Corticosteroids and plasma exchange in multiple sclerosis (English)

1 reference

20 August 2017

0 references

Hayretin Tumani

1

1 reference

20 August 2017

1 December 2008

1 reference

20 August 2017

1 reference

20 August 2017

255 Suppl 6

1 reference

20 August 2017

36-42

1 reference

https://scigraph.springernature.com/pub.10.1007/s00415-008-6007-9

20 August 2017

0 references

cites work

A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. The Optic Neuritis Study Group

1 reference

https://api.crossref.org/works/10.1007%2FS00415-008-6007-9

The bioavailability of IV methylprednisolone and oral prednisone in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-008-6007-9

Randomized trial comparing two different high doses of methylprednisolone in MS: a clinical and MRI study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-008-6007-9

Plasma exchange for severe optic neuritis: treatment of 10 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-008-6007-9

Double-blind study of true vs. sham plasma exchange in patients treated with immunosuppression for acute attacks of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-008-6007-9

Effects of IV methylprednisolone on brain atrophy in relapsing-remitting MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-008-6007-9

Plasma exchange in neuroimmunological disorders: Part 1: Rationale and treatment of inflammatory central nervous system disorders

21 January 2018

1 reference

12 December 2020

Plasma exchange therapy for steroid-unresponsive multiple sclerosis relapses: clinical experience with 16 patients

1 reference

12 December 2020

The Canadian cooperative trial of cyclophosphamide and plasma exchange in progressive multiple sclerosis. The Canadian Cooperative Multiple Sclerosis Study Group

1 reference

12 December 2020

Corticosteroids or ACTH for acute exacerbations in multiple sclerosis

1 reference

12 December 2020

Corticosteroids for the long-term treatment in multiple sclerosis

1 reference

12 December 2020

Mechanism of action of glucocorticosteroid hormones: possible implications for therapy of neuroimmunological disorders

1 reference

12 December 2020

Randomised trial of oral and intravenous methylprednisolone in acute relapses of multiple sclerosis

1 reference

12 December 2020

Avonex Combination Trial in relapsing--remitting MS: rationale, design and baseline data

1 reference

12 December 2020

Corticosteroids for multiple sclerosis: I. Application for treating exacerbations

1 reference

12 December 2020

A phase II study of i.v. methylprednisolone in secondary-progressive multiple sclerosis

1 reference

12 December 2020

Therapeutic plasma exchange for acute inflammatory demyelinating syndromes of the central nervous system

1 reference

12 December 2020

Relative efficacy of intravenous methylprednisolone and ACTH in the treatment of acute relapse in MS

1 reference

12 December 2020

The optic neuritis treatment trial: three-year follow-up results

1 reference

12 December 2020

Repeat intrathecal triamcinolone acetonide application reduces acute occurring painful dysesthesia in patients with relapsing remitting multiple sclerosis.

1 reference

12 December 2020

Efficacy of repeated intrathecal triamcinolone acetonide application in progressive multiple sclerosis patients with spinal symptoms

1 reference

12 December 2020

Antigen therapy of experimental autoimmune encephalomyelitis selectively induces apoptosis of pathogenic T cells.

1 reference

12 December 2020

Methylprednisolone in multiple sclerosis: a comparison of oral with intravenous therapy at equivalent high dose

1 reference

12 December 2020

A double-blind controlled trial of high dose methylprednisolone in patients with multiple sclerosis: 1. Clinical effects

1 reference

12 December 2020

USE OF AN ORAL CORTICOSTEROID IN THE TREATMENT OF MULTIPLE SCLEROSIS; A DOUBLE-BLIND STUDY

1 reference

12 December 2020

[Escalating immunomodulatory therapy of multiple sclerosis. Update (September 2006)]

1 reference

12 December 2020

Relation between humoral pathological changes in multiple sclerosis and response to therapeutic plasma exchange

1 reference

12 December 2020

A double-blind controlled trial of high dose methylprednisolone in patients with multiple sclerosis: 2. Laboratory results

1 reference

12 December 2020

Chronic progressive multiple sclerosis: double-blind controlled study of plasmapheresis in patients taking immunosuppressive drugs

1 reference

12 December 2020

Plasma exchange therapy for steroid-refractory superimposed relapses in secondary progressive multiple sclerosis

1 reference

12 December 2020

10.1007/S00415-008-6007-9

Identifiers

DOI

1 reference

20 August 2017

1 reference

PubMed ID

19300958